Cooper/Haims Advisors, LLC Abb Vie Inc. Transaction History

Cooper/Haims Advisors, LLC

$179 Million
Q3 2024

A detailed history of Cooper/Haims Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cooper/Haims Advisors, LLC holds 2,960 shares of ABBV stock, worth $526,909. This represents 0.33% of its overall portfolio holdings.

Number of Shares

2,960

Previous 2,960 -0.0%

Holding current value

$526,909

Previous $507,000 15.19%

% of portfolio

0.33%

Previous 0.29%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $60,987 - $71,219	-394 Reduced 11.75%	2,960 $507,000
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $1,917 - $2,185	-12 Reduced 0.36%	3,354 $610,000
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $68,387 - $77,020	-497 Reduced 12.87%	3,366 $521,000
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $2,538 - $2,938	-19 Reduced 0.49%	3,863 $575,000
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $3,047 - $3,792	23 Added 0.6%	3,882 $523,000
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $18,076 - $20,817	-125 Reduced 3.14%	3,859 $615,000
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $38,865 - $46,609	-281 Reduced 6.59%	3,984 $644,000
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $268 - $307	2 Added 0.05%	4,265 $572,000
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $17,340 - $22,044	126 Added 3.05%	4,263 $653,000
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $158,244 - $196,336	-1,199 Reduced 22.47%	4,137 $671,000
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $85 - $100	1 Added 0.02%	5,336 $467,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1,247 - $1,669	17 Added 0.32%	5,335 $524,000
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $36,065 - $45,125	500 Added 10.38%	5,318 $471,000
Q2 2019 Jul 26, 2019	SELL	$65.7 - $83.98 $65,700 - $83,980	-1,000 Reduced 17.19%	4,818 $350,000
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $185,521 - $218,349	-2,405 Reduced 29.25%	5,818 $469,000
Q1 2019 Apr 26, 2019	BUY	$77.14 - $90.79 $185,521 - $218,349	2,405 Added 41.34%	8,223 $663,000
Q4 2018 Jan 25, 2019	SELL	$77.85 - $96.01 $37,445 - $46,180	-481 Reduced 7.64%	5,818 $536,000
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $90,139 - $106,654	1,004 Added 18.96%	6,299 $584,000
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $474,220 - $520,021	5,295	5,295 $512,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper/Haims Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cooper/Haims Advisors, LLC with notifications on news.

Account

Cooper/Haims Advisors, LLC Abb Vie Inc. Transaction History